BVF INC/IL - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 82 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2019$14,727,000
-54.2%
183,834
-58.0%
1.12%
-66.9%
Q3 2019$32,148,000
-22.1%
437,5650.0%3.38%
-25.1%
Q2 2019$41,276,000
-8.7%
437,565
-22.6%
4.51%
-11.0%
Q1 2019$45,225,000
+45.9%
564,965
-1.7%
5.06%
+25.0%
Q4 2018$30,996,000
-33.6%
574,967
-3.9%
4.05%
-1.3%
Q3 2018$46,701,000
+13.7%
598,267
-7.5%
4.10%
+2.4%
Q2 2018$41,060,000
-31.7%
646,811
-1.3%
4.01%
-34.2%
Q1 2018$60,120,000
+3.9%
655,611
-14.6%
6.09%
-12.6%
Q4 2017$57,866,000
-17.5%
767,354
-23.8%
6.98%
-21.8%
Q3 2017$70,182,000
-13.0%
1,007,354
-36.7%
8.92%
-28.8%
Q2 2017$80,649,000
-4.1%
1,591,646
-24.3%
12.52%
-12.4%
Q1 2017$84,070,000
-7.9%
2,102,280
-35.4%
14.30%
-22.1%
Q4 2016$91,311,000
+11.2%
3,255,280
+17.7%
18.35%
+18.6%
Q3 2016$82,123,000
+40.1%
2,765,080
-4.5%
15.48%
+23.9%
Q2 2016$58,629,000
+23.0%
2,895,251
+9.7%
12.49%
+5.9%
Q1 2016$47,657,000
-20.6%
2,640,251
+15.9%
11.79%
+15.3%
Q4 2015$60,015,000
+65.2%
2,278,459
+33.8%
10.23%
+39.3%
Q3 2015$36,335,000
-13.3%
1,702,654
+7.6%
7.34%
-0.8%
Q2 2015$41,918,0001,582,4087.40%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders